Finance ❯ Investments ❯ Stock Market

Securities

Investor Losses Investor Rights Investor Protection Investor Relations Class Action Lawsuits Market Performance Market Analysis Market Regulation Fraudulent Practices Class Action Claims

3 ARTICLES

last mo.

Multiple Law Firms Seek Globant Investors After Securities Fraud Complaint

Shareholder notices invite investors to join a class action that alleges the company misled the market about its Latin American strategy and workforce issues.

4 ARTICLES

last mo.

Multiple Plaintiff Firms Court Investors in Pinterest Securities Suit

6 ARTICLES

last mo.

Securities Suit Filed Over Stellantis’ €22.2 Billion ‘Reset’ as Firms Race to Be Lead Plaintiff

4 ARTICLES

last mo.

Gossamer Bio Faces Class Actions After Phase 3 PROSERA Misses Primary Endpoint

8 ARTICLES

last mo.

DOJ Indictment Over Alleged Diversion of AI Servers Fuels Competing Super Micro Securities Suits

7 ARTICLES

last mo.

Plaintiff Firms Race to Lead Securities Suit Against Sportradar

5 ARTICLES

last mo.

Securities Class Action Targets New Era Energy Over Alleged Oil‑and‑Gas Revenue Scheme

5 ARTICLES

last mo.

Investors File Securities Class Action Against Graphic Packaging in SDNY

4 ARTICLES

last mo.

Gartner Investors Urged to Seek Lead-Plaintiff Role as May 18 Deadline Nears

8 ARTICLES

2mo ago

ImmunityBio Investors Face May 26 Deadline in Securities Class Action Over FDA Ad Rebuke

7 ARTICLES

2mo ago

SES AI Faces Investor Class Action as Firms Recruit Lead Plaintiffs

4 ARTICLES

2mo ago

Graphic Packaging Sued in New York Securities Class Action Over Inventory and Guidance Claims

3 ARTICLES

2mo ago

Law Firms Urge Grocery Outlet Investors to Seek Lead Role in Securities Suit Before May 15

6 ARTICLES

2mo ago

FS KKR Investors Face Early July Deadline to Seek Lead Role in Securities Case

10 ARTICLES

2mo ago

Camping World Investors Face May 11 Deadline in Securities Class Action

5 ARTICLES

2mo ago

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

6 ARTICLES

2mo ago

Super Micro Investors Face May 26 Deadline in Securities Suits Tied to DOJ China-Export Case

3 ARTICLES

2mo ago

Gartner Faces Investor Class Action Over Consulting and Contract-Value Disclosures

4 ARTICLES

2mo ago

Gossamer Bio Investors Face June 1 Deadline in Securities Class Action

7 ARTICLES

2mo ago

ImmunityBio Investors Urged to Seek Lead Role in Suit After FDA Rebuke Over Anktiva Ads

Securities

Multiple Law Firms Seek Globant Investors After Securities Fraud Complaint

Multiple Plaintiff Firms Court Investors in Pinterest Securities Suit

Securities Suit Filed Over Stellantis’ €22.2 Billion ‘Reset’ as Firms Race to Be Lead Plaintiff

Gossamer Bio Faces Class Actions After Phase 3 PROSERA Misses Primary Endpoint

DOJ Indictment Over Alleged Diversion of AI Servers Fuels Competing Super Micro Securities Suits

Plaintiff Firms Race to Lead Securities Suit Against Sportradar

Securities Class Action Targets New Era Energy Over Alleged Oil‑and‑Gas Revenue Scheme

Investors File Securities Class Action Against Graphic Packaging in SDNY

Gartner Investors Urged to Seek Lead-Plaintiff Role as May 18 Deadline Nears

ImmunityBio Investors Face May 26 Deadline in Securities Class Action Over FDA Ad Rebuke

Never miss stories about

Securities

SES AI Faces Investor Class Action as Firms Recruit Lead Plaintiffs

Graphic Packaging Sued in New York Securities Class Action Over Inventory and Guidance Claims

Law Firms Urge Grocery Outlet Investors to Seek Lead Role in Securities Suit Before May 15

FS KKR Investors Face Early July Deadline to Seek Lead Role in Securities Case

Camping World Investors Face May 11 Deadline in Securities Class Action

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

Super Micro Investors Face May 26 Deadline in Securities Suits Tied to DOJ China-Export Case

Gartner Faces Investor Class Action Over Consulting and Contract-Value Disclosures

Gossamer Bio Investors Face June 1 Deadline in Securities Class Action

ImmunityBio Investors Urged to Seek Lead Role in Suit After FDA Rebuke Over Anktiva Ads

Never miss stories about

Securities